We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+18.4%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.28B
AUM Growth
+$253M
Cap. Flow
+$143M
Cap. Flow %
11.17%
Top 10 Hldgs %
13.47%
Holding
1,446
New
471
Increased
321
Reduced
302
Closed
327

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$16.8M
2
U icon
Unity
U
+$14M
3
AIFC
AI Financial Corp
AIFC
+$13.8M
4
CYBR
CyberArk
CYBR
+$12.6M
5
NSC icon
Norfolk Southern
NSC
+$11.7M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$13.2M
2
TSLA icon
Tesla
TSLA
+$12.9M
3
BIDU icon
Baidu
BIDU
+$11.9M
4
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$10M
5
AMED
Amedisys
AMED
+$8.89M

Sector Composition

Rank Sector Weight
1 Technology 21.32%
2 Communication Services 11.38%
3 Healthcare 11.08%
4 Consumer Discretionary 10.37%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SDRL icon
151
Seadrill
SDRL
$2.7B
$2.11M 0.16%
69,868
-8,663
-11% -$264K
CPRI icon
152
Capri Holdings
CPRI
$1.74B
$2.1M 0.16%
105,265
-31,082
-23% -$623K
MSTY icon
153
YieldMax MSTR Option Income Strategy ETF
MSTY
$777M
$2.09M 0.16%
30,000
+10,000
+50% +$909K
GLIBK
154
Liberty Capital Corp Series C GCI Group Common Stock
GLIBK
$958M
$2.09M 0.16%
+56,100
New +$1.98M
BBIO icon
155
BridgeBio Pharma
BBIO
$16.5B
$2.07M 0.16%
39,849
-10,974
-22% -$535K
ICVT icon
156
iShares Convertible Bond ETF
ICVT
$7.46B
$2.05M 0.16%
+20,521
New +$1.93M
KRG icon
157
Kite Realty
KRG
$5.36B
$2.05M 0.16%
91,898
+3,298
+4% +$73.6K
FLOT icon
158
iShares Floating Rate Bond ETF
FLOT
$10.5B
$2.04M 0.16%
40,026
+7,530
+23% +$384K
EWZ icon
159
iShares MSCI Brazil ETF
EWZ
$8.95B
$2.03M 0.16%
65,377
+8,114
+14% +$232K
MRVL icon
160
Marvell Technology
MRVL
$196B
$2.01M 0.16%
23,928
+6,090
+34% +$448K
HBI
161
DELISTED
Hanesbrands
HBI
$2M 0.16%
302,792
+291,761
+2,645% +$1.61M
SCHL icon
162
Scholastic
SCHL
$792M
$1.99M 0.16%
+72,676
New +$1.8M
HOOD icon
163
Robinhood
HOOD
$83.9B
$1.99M 0.16%
13,897
+2,347
+20% +$256K
ENSG icon
164
The Ensign Group
ENSG
$10.7B
$1.99M 0.16%
+11,501
New +$1.83M
HCA icon
165
HCA Healthcare
HCA
$89.5B
$1.98M 0.15%
4,655
-945
-17% -$366K
INDA icon
166
iShares MSCI India ETF
INDA
$6.63B
$1.98M 0.15%
+38,033
New +$2.03M
COGT icon
167
Cogent Biosciences
COGT
$7.24B
$1.97M 0.15%
137,281
-25,900
-16% -$307K
GEV icon
168
GE Vernova
GEV
$264B
$1.96M 0.15%
3,181
-1,574
-33% -$954K
FINV
169
FinVolution Group
FINV
$1.15B
$1.92M 0.15%
+260,292
New +$2.28M
IBM icon
170
IBM
IBM
$224B
$1.92M 0.15%
6,790
+2,209
+48% +$578K
RIOT icon
171
Riot Platforms
RIOT
$7.76B
$1.91M 0.15%
+100,317
New +$1.39M
BFIN
172
DELISTED
BankFinancial
BFIN
$1.9M 0.15%
+157,681
New +$1.87M
PANW icon
173
Palo Alto Networks
PANW
$297B
$1.9M 0.15%
9,312
+4,556
+96% +$872K
DAL icon
174
Delta Air Lines
DAL
$60.1B
$1.87M 0.15%
32,887
+3,301
+11% +$188K
BE icon
175
Bloom Energy
BE
$64.6B
$1.86M 0.15%
22,049
-4,340
-16% -$202K
5 6
7
8 9

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Prelude Capital Management held 1,446 positions worth $1.28B, up 25% from $1.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Prelude Capital Management deployed $143M of net new capital in Q3 2025, opening 471 new positions and adding to 321 existing holdings. Its largest new stake was Verona Pharma: 160,565 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $13.2M trimmed.

  • Prelude Capital Management's largest Q3 2025 buy was Verona Pharma: 160,565 shares worth $17.1M.
  • Prelude Capital Management added most to Amazon in Q3 2025, an estimated $11.4M increase.
  • Prelude Capital Management's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $13.2M.
  • Prelude Capital Management fully exited Amedisys in Q3 2025, selling an estimated $8.89M.
  • Prelude Capital Management's ten largest holdings make up 13% of its $1.28B portfolio in Q3 2025.
  • Prelude Capital Management opened 471 new positions and closed 327 in Q3 2025.
  • Prelude Capital Management's portfolio value rose 25% quarter-over-quarter to $1.28B.

Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.